SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-061105
Filing Date
2023-11-08
Accepted
2023-11-08 16:10:09
Documents
13
Period of Report
2023-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asmb-20231108.htm   iXBRL 8-K 52969
2 EX-99.1 asmb-ex99_1.htm EX-99.1 266721
  Complete submission text file 0000950170-23-061105.txt   456781

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asmb-20231108_lab.xml EX-101.LAB 17952
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asmb-20231108.xsd EX-101.SCH 2483
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asmb-20231108_pre.xml EX-101.PRE 11124
7 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20231108_htm.xml XML 4720
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 231387910
SIC: 2834 Pharmaceutical Preparations